Dr Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer
4th Jun 2006, 05:54 GMT
Cardium Therapeutics appointed Gabor M Rubanyi, MD, Ph.D as Chief Scientific Officer.
Dr Gabor Rubanyi of Berlex Biosciences Joins Cardium as Chief Scientific Officer related news:
- Affibody AB appoints Dr. Ulf Boberg as Chief Executive Officer — ArriveNet : Health
- Amarillo Biosciences Sponsors Oral Interferon Study of Influenza in Humans — ArriveNet : Health
- Amarillo Biosciences, Inc. : Amarillo Biosciences Sponsors Oral Interferon Study of Influenza in Humans — Market Wire - Pharmaceuticals and Biotech
- Hoku Scientific Chief Executive Officer to Present at SG Cowen Technology Conference — ArriveNet : Autos
- ImmuneRegen BioSciences and Oak Ridge National Laboratory Announce Initial Results From Radilex Testing — ORNL in the News
- ZIOPHARM Appoints Brian Schwartz, M.D. As Chief Medical Officer; Key Physician Responsible for the Global Clinical Development of Sorafenib (Nexavar(R)) — RedOrbit News - Health
- Affibody AB appoints Dr. Ulf Boberg as Chief Executive — WebWire - Recent Headlines
- Dr. Carlos Melo: BioTech Nation — Tech Nation w/Moira Gunn
- GE chief meets Lalu, top PMO officials — Sify.com Finance
- Buffalo Gold Ltd.: Brian McEwen Joins Buffalo Gold as its President and Chief Operating Officer — Market Wire - Manufacturing and Production
Latest news from Angiography/ Cardiac Cath News from StratCenter.com:
- Thinking Systems Releases Enhanced PET-CT Functions for Its ThinkingPACS
- Tallahassee Memorial Hospital at the Forefront in Treatment of Heart Attack Patients
- Preliminary Long-Term Clinical Data Show Promising Results for the CYPHER Sirolimus-eluting Coronary Stent in Patients With Multi-Vessel Disease